stock.name

Durect Corp

DRRX

Market Cap$37.29M
Close$

Compare Durect

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Durect CorpDurect Corp-10%-254%-1.3
marketMarket Avg59.61.27%31%6.41
HealthcareHealthcare Avg62.31.27%15%7.30.9
$1.39

Current Fair Value

3.8% upside

Undervalued by 3.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$37.29 Million
Enterprise Value$17.00 Million
Dividend Yield$0.0 (0.0%)
Earnings per Share$-1.48
Beta1.64
Outstanding Shares29,828,891
Avg 30 Day Volume170,462

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-1.02
PEG-4.62
Price to Sales-
Price to Book Ratio-
Enterprise Value to Revenue1.85
Enterprise Value to EBIT-0.4
Enterprise Value to Net Income-1
Total Debt to Enterprise1.1
Debt to Equity1.3

Revenue Sources

No data

ESG Score

No data

About Durect Corp

CEO: James Brown

DURECT is a biopharmaceutical company committed to transforming the treatment of acute organ injury and chronic liver diseases by advancing novel and potentially lifesaving therapies based on its endogenous epigenetic regulator program. ...